Email this article Divitren in postmenopausal climacteric disorders treatment
- Authors: Nikanorova S.A.1
-
Affiliations:
- Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
- Issue: Vol 49, No 2 (2000)
- Pages: 17-20
- Section: Original study articles
- URL: https://journals.rcsi.science/jowd/article/view/89078
- DOI: https://doi.org/10.17816/JOWD89078
- ID: 89078
Cite item
Full Text
Abstract
In the article the data of clinical examination on Divitren application for climacteric syndrome treatment in postmenopausal women are given. The drug has shown a few side-effects, there are revealed a significant Cuperman index, gonadotropin levels decrease and estradiol level increase. The received data is evident for proper ground of Divitren application in flush disturbances treatment in postmenopausal women.
Full Text
##article.viewOnOriginalSite##About the authors
S. A. Nikanorova
Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg
References
Supplementary files
Supplementary Files
Action
1.
JATS XML
2.
Fig. 1. FSH content in postmenopausal women before treatment and when taking Divitren (p<0.05).
Download (1MB)
3.
Fig. 2. LH content in postmenopausal women before treatment and when taking Divitren (p<0.05).
Download (1MB)
4.
Fig. 3. Estradiol content in postmenopausal women before treatment and when taking Divitren (p<0.05).
Download (1MB)
5.
Fig. 4. Prolactin content in postmenopausal women before treatment and when taking Divitren.
Download (1MB)
6.
Fig. 5. Cooperman's index.
Download (1MB)
